| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |